Marshall Wace, LLP Mustang Bio, Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.73 - $1.81 $30,951 - $76,742	-42,399 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $70,382 - $111,933	42,399 New	42,399 $70,000
Q4 2020 Feb 16, 2021	SELL	$2.66 - $4.18 $55,607 - $87,382	-20,905 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $62,924 - $81,111	20,905 New	20,905 $66,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.